Pirouette is a pharmaceutical company poised to revolutionize healthcare accessibility. New injectable medications are being developed constantly, fueling a $600B market, but there has been no real innovation on delivery. It's time to reimagine injections. Pirouette’s un-intimidating auto-injector platform aims to improve the patient experience through affordable, stress-free, and intuitive simplicity. Pirouette has prioritized two flagship products for the emergency treatment of opioid overdoses (Naloxone) and severe allergic reactions (Epinephrine).